Filing Details

Accession Number:
0001708138-20-000042
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-20 19:26:56
Reporting Period:
2020-04-16
Accepted Time:
2020-04-20 19:26:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238303 J Joseph Larosa 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp General Counsel And Secret No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-16 5,000 $59.20 19,438 No 4 M Direct
Common Stock Disposition 2020-04-16 2,733 $529.79 16,705 No 4 F Direct
Common Stock Disposition 2020-04-17 95 $541.94 16,610 No 4 S Direct
Common Stock Disposition 2020-04-17 5 $542.31 16,605 No 4 S Direct
Common Stock Disposition 2020-04-17 100 $547.00 16,505 No 4 S Direct
Common Stock Disposition 2020-04-17 99 $548.27 16,406 No 4 S Direct
Common Stock Disposition 2020-04-17 100 $549.24 16,306 No 4 S Direct
Common Stock Disposition 2020-04-17 6 $550.00 16,300 No 4 S Direct
Common Stock Disposition 2020-04-17 104 $552.85 16,196 No 4 S Direct
Common Stock Disposition 2020-04-17 114 $555.10 16,082 No 4 S Direct
Common Stock Disposition 2020-04-17 198 $556.51 15,884 No 4 S Direct
Common Stock Disposition 2020-04-17 93 $557.40 15,791 No 4 S Direct
Common Stock Disposition 2020-04-17 293 $558.55 15,498 No 4 S Direct
Common Stock Disposition 2020-04-17 285 $559.79 15,213 No 4 S Direct
Common Stock Disposition 2020-04-17 163 $560.38 15,050 No 4 S Direct
Common Stock Disposition 2020-04-17 63 $561.76 14,987 No 4 S Direct
Common Stock Disposition 2020-04-17 191 $562.56 14,796 No 4 S Direct
Common Stock Disposition 2020-04-17 171 $563.39 14,625 No 4 S Direct
Common Stock Disposition 2020-04-17 93 $564.19 14,532 No 4 S Direct
Common Stock Disposition 2020-04-17 94 $565.92 14,438 No 4 S Direct
Common Stock Acquisiton 2020-04-17 6,622 $59.20 21,060 No 4 M Direct
Common Stock Disposition 2020-04-17 3,602 $555.82 17,458 No 4 F Direct
Common Stock Acquisiton 2020-04-17 5,000 $59.20 22,458 No 4 M Direct
Common Stock Disposition 2020-04-17 2,720 $555.82 19,738 No 4 F Direct
Common Stock Disposition 2020-04-20 51 $561.57 19,687 No 4 S Direct
Common Stock Disposition 2020-04-20 21 $562.71 19,666 No 4 S Direct
Common Stock Disposition 2020-04-20 416 $563.58 19,250 No 4 S Direct
Common Stock Disposition 2020-04-20 377 $564.74 18,873 No 4 S Direct
Common Stock Disposition 2020-04-20 1,468 $565.60 17,405 No 4 S Direct
Common Stock Disposition 2020-04-20 1,189 $566.44 16,216 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 198 shares of Company stock on April 17, 2020 at prices ranging from $556.43 to $556.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 17, 2020 at each separate price.
  3. Represents volume-weighted average price of sales of 293 shares of Company stock on April 17, 2020 at prices ranging from $558.42 to $558.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 17, 2020 at each separate price.
  4. Represents volume-weighted average price of sales of 285 shares of Company stock on April 17, 2020 at prices ranging from $559.47 to $559.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 17, 2020 at each separate price.
  5. Represents volume-weighted average price of sales of 163 shares of Company stock on April 17, 2020 at prices ranging from $560.27 to $560.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 17, 2020 at each separate price.
  6. Represents volume-weighted average price of sales of 191 shares of Company stock on April 17, 2020 at prices ranging from $562.31 to $562.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 17, 2020 at each separate price.
  7. Represents volume-weighted average price of sales of 171 shares of Company stock on April 17, 2020 at prices ranging from $563.33 to $563.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 17, 2020 at each separate price.
  8. Represents volume-weighted average price of sales of 94 shares of Company stock on April 17, 2020 at prices ranging from $565.77 to $565.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 17, 2020 at each separate price.
  9. Represents volume-weighted average price of sales of 416 shares of Company stock on April 20, 2020 at prices ranging from $563.35 to $563.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
  10. Represents volume-weighted average price of sales of 377 shares of Company stock on April 20, 2020 at prices ranging from $564.03 to $564.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
  11. Represents volume-weighted average price of sales of 1,468 shares of Company stock on April 20, 2020 at prices ranging from $565.03 to $565.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
  12. Represents volume-weighted average price of sales of 1,189 shares of Company stock on April 20, 2020 at prices ranging from $566.00 to $566.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 20, 2020 at each separate price.
  13. Form one of two